These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 29721731)
1. Assessment of the direct effects of DDAH I on tumour angiogenesis in vivo. Papaevangelou E; Boult JKR; Whitley GS; Robinson SP; Howe FA Angiogenesis; 2018 Nov; 21(4):737-749. PubMed ID: 29721731 [TBL] [Abstract][Full Text] [Related]
2. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA). Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732 [TBL] [Abstract][Full Text] [Related]
3. Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. Boult JK; Walker-Samuel S; Jamin Y; Leiper JM; Whitley GS; Robinson SP J Pathol; 2011 Nov; 225(3):344-52. PubMed ID: 21590769 [TBL] [Abstract][Full Text] [Related]
4. Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging. Kostourou V; Robinson SP; Whitley GS; Griffiths JR Cancer Res; 2003 Aug; 63(16):4960-6. PubMed ID: 12941821 [TBL] [Abstract][Full Text] [Related]
6. A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1. Buijs N; Oosterink JE; Jessup M; Schierbeek H; Stolz DB; Houdijk AP; Geller DA; van Leeuwen PA Angiogenesis; 2017 Nov; 20(4):557-565. PubMed ID: 28741166 [TBL] [Abstract][Full Text] [Related]
7. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151 [TBL] [Abstract][Full Text] [Related]
8. Investigating the role of tumour cell derived iNOS on tumour growth and vasculature in vivo using a tetracycline regulated expression system. Papaevangelou E; Whitley GS; Johnstone AP; Robinson SP; Howe FA Int J Cancer; 2016 Jun; 138(11):2678-87. PubMed ID: 26756734 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells. Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664 [TBL] [Abstract][Full Text] [Related]
10. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis. Lange C; Mowat F; Sayed H; Mehad M; Duluc L; Piper S; Luhmann U; Nandi M; Kelly P; Smith A; Ali R; Leiper J; Bainbridge J Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226 [TBL] [Abstract][Full Text] [Related]
11. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion. Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305 [TBL] [Abstract][Full Text] [Related]
12. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Leiper J; Murray-Rust J; McDonald N; Vallance P Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13527-32. PubMed ID: 12370443 [TBL] [Abstract][Full Text] [Related]
13. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine. Feng M; Liu L; Guo Z; Xiong Y Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305 [TBL] [Abstract][Full Text] [Related]